Polygenic risk score | Cohorts of adult women | Quintile of polygenic score | Â | Model 1 | Model 2 | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Q1 | Q2 | Q3 | Q4 | Q5 | Test | Pmodel 1 | PQ | Pmodel 2 | PQ | ||
PRSTC | Cohort 1 | 0.0481 (0.0466–0.0497) | 0.0496 (0.0482–0.0511) | 0.0503 (0.0487–0.0520) | 0.0501 (0.0486–0.0516) | 0.0497 (0.0482–0.0514) | Linear trend | 0.0534 |  | 0.1003 |  |
Cohort 2 | 0.0481 (0.0450–0.0515) | 0.0504 (0.0453–0.0561) | 0.0529 (0.0479–0.0584) | 0.0550 (0.0496–0.0610) | 0.0512 (0.0479–0.0547) | Linear trend | 0.1032 |  | 0.0758 |  | |
 |  |  |  |  |  | Meta-analysis | 0.0182 | 0.3547 | 0.0315 | 0.2560 | |
Cohort 1 | 0.0495 (0.0488–0.0503) | 0.0497 (0.0482–0.0514) | Top 20% vs others | 0.6893 |  | 0.7445 |  | ||||
Cohort 2 | 0.0518 (0.0493–0.0544) | 0.0512 (0.0479–0.0547) | Top 20% vs others | 0.8236 |  | 0.9732 |  | ||||
 |  |  |  |  |  | Meta-analysis | 0.7591 | 0.7336 | 0.7667 | 0.8891 | |
PRSTG | Cohort 1 | 0.0499 (0.0485–0.0514) | 0.0498 (0.0481–0.0515) | 0.0491 (0.0475–0.0507) | 0.0494 (0.0481–0.0507) | 0.0498 (0.0480–0.0516) | Linear trend | 0.7416 |  | 0.7173 |  |
Cohort 2 | 0.0515 (0.0471–0.0563) | 0.0514 (0.0481–0.0548) | 0.0512 (0.0477–0.0549) | 0.0542 (0.0457–0.0643) | 0.0507 (0.0469–0.0548) | Linear trend | 0.6197 |  | 0.9116 |  | |
 |  |  |  |  |  | Meta-analysis | 0.6430 | 0.7068 | 0.7048 | 0.9963 | |
Cohort 1 | 0.0495 (0.0488–0.0503) | 0.0498 (0.0480–0.0516) | Top 20% vs others | 0.9536 |  | 0.9879 |  | ||||
Cohort 2 | 0.0518 (0.0495–0.0542) | 0.0507 (0.0469–0.0548) | Top 20% vs others | 0.4509 |  | 0.9879 |  | ||||
 |  |  |  |  |  | Meta-analysis | 0.8786 | 0.4574 | 0.9917 | 0.9849 | |
PRSHDL | Cohort 1 | 0.0512 (0.0497–0.0527) | 0.0490 (0.0475–0.0505) | 0.0496 (0.0479–0.0513) | 0.0483 (0.0469–0.0498) | 0.0498 (0.0482–0.0514) | Linear trend | 0.3786 |  | 0.3242 |  |
 | Cohort 2 | 0.0511 (0.0470–0.0556) | 0.0542 (0.0466–0.0630) | 0.0498 (0.0459–0.0539) | 0.0532 (0.0491–0.0576) | 0.0508 (0.0475–0.0542) | Linear trend | 0.9307 |  | 0.8528 |  |
 |  |  |  |  |  |  | Meta-analysis | 0.4194 | 0.7165 | 0.3205 | 0.8838 |
 | Cohort 1 | 0.0512 (0.0497–0.0527) | 0.0492 (0.0484–0.0500) | Bottom 20% vs others | 0.0212 |  | 0.0160 |  | |||
 | Cohort 2 | 0.0511 (0.0470–0.0556) | 0.0518 (0.0495–0.0542) | Bottom 20% vs others | 0.4012 |  | 0.4524 |  | |||
 |  |  |  |  |  |  | Meta-analysis | 0.0533 | 0.1286 | 0.0405 | 0.1373 |
PRSLDL | Cohort 1 | 0.0481 (0.0467–0.0495) | 0.0498 (0.0484–0.0513) | 0.0489 (0.0475–0.0503) | 0.0514 (0.0494–0.0536) | 0.0495 (0.0482–0.0509) | Linear trend | 0.0485 |  | 0.0954 |  |
 | Cohort 2 | 0.0509 (0.0452–0.0574) | 0.0516 (0.0458–0.0581) | 0.0533 (0.0485–0.0585) | 0.0545 (0.0504–0.0590) | 0.0490 (0.0465–0.0517) | Linear trend | 0.9030 |  | 0.7916 |  |
 |  |  |  |  |  |  | Meta-analysis | 0.0570 | 0.5840 | 0.0972 | 0.7430 |
 | Cohort 1 | 0.0496 (0.0488–0.0504) | 0.0495 (0.0482–0.0509) | Top 20% vs others | 0.7463 |  | 0.7438 |  | |||
 | Cohort 2 | 0.0526 (0.0500–0.0553) | 0.0490 (0.0465–0.0517) | Top 20% vs others | 0.2775 |  | 0.3636 |  | |||
 |  |  |  |  |  |  | Meta-analysis | 0.9340 | 0.2564 | 0.9800 | 0.3328 |